Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 4547953, 7 pages
http://dx.doi.org/10.1155/2016/4547953
Research Article

The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils

Department of Systems Medicine, University of Rome Tor Vergata, Chair of Respiratory Medicine, Rome, Italy

Received 14 June 2016; Revised 14 September 2016; Accepted 27 September 2016

Academic Editor: Fabrizio Luppi

Copyright © 2016 Paola Rogliani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Saha and C. E. Brightling, “Eosinophilic airway inflammation in COPD,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 1, no. 1, pp. 39–47, 2006. View at Google Scholar
  2. G. Balzano, F. Stefanelli, C. Iorio et al., “Eosinophilic inflammation in stable chronic obstructive pulmonary disease: relationship with neutrophils and airway function,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 5, part 1, pp. 1486–1492, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Pizzichini, M. M. M. Pizzichini, P. Gibson et al., “Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 5, pp. 1511–1517, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. D.-W. Perng, H.-Y. Huang, H.-M. Chen, Y.-C. Lee, and R.-P. Perng, “Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment,” Chest, vol. 126, no. 2, pp. 375–381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Saetta, A. Di Stefano, P. Maestrelli et al., “Airway eosinophilia in chronic bronchitis during exacerbations,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 6 I, pp. 1646–1652, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-J. Tsai, E.-C. Liao, J.-Y. Hsu, W.-J. Lee, and Y.-K. Lai, “The differences of eosinophil- and neutrophil-related inflammation in elderly allergic and non-allergic chronic obstructive pulmonary disease,” Journal of Asthma, vol. 47, no. 9, pp. 1040–1044, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Chanez, A. M. Vignola, T. O'Shaugnessy et al., “Corticosteroid reversibility in COPD is related to features of asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 5, pp. 1529–1534, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. C. E. Brightling, W. Monteiro, R. Ward et al., “Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial,” The Lancet, vol. 356, no. 9240, pp. 1480–1485, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Kitaguchi, Y. Komatsu, K. Fujimoto, M. Hanaoka, and K. Kubo, “Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 7, pp. 283–289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Bafadhel, S. McKenna, S. Terry et al., “Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 1, pp. 48–55, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Pascoe, N. Locantore, M. T. Dransfield, N. C. Barnes, and I. D. Pavord, “Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials,” The Lancet Respiratory Medicine, vol. 3, no. 6, pp. 435–442, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Papi, M. Romagnoli, S. Baraldo et al., “Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 5, pp. 1773–1777, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Sitkauskiene, R. Sakalauskas, K. Malakauskas, and J. Lötvall, “Reversibility to a β2-agonist in COPD: relationship to atopy and neutrophil activation,” Respiratory Medicine, vol. 97, no. 6, pp. 591–598, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. D'Armiento, S. M. Scharf, M. D. Roth et al., “Eosinophil and T cell markers predict functional decline in COPD patients,” Respiratory Research, vol. 10, article 113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Nishimura, H. Makita, K. Nagai et al., “Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 185, no. 1, pp. 44–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. R. L. Di Santostefano, D. Hinds, H. Van Le, and N. C. Barnes, “Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort,” Respiratory Medicine, vol. 112, pp. 88–96, 2016. View at Publisher · View at Google Scholar
  17. M. Miravitlles, M. Calle, and J. J. Soler-Cataluna, “Clinical phenotypes of COPD: identification, definition and implications for guidelines,” Archivos de Bronconeumologia, vol. 48, no. 3, pp. 86–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Segreti, E. Stirpe, P. Rogliani, and M. Cazzola, “Defining phenotypes in COPD: an aid to personalized healthcare,” Molecular Diagnosis and Therapy, vol. 18, no. 4, pp. 381–388, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Cazzola, A. Segreti, G. Bettoncelli et al., “Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008,” Primary Care Respiratory Journal, vol. 20, no. 3, pp. 291–298, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Stănescu, A. Sanna, C. Veriter et al., “Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils,” Thorax, vol. 51, no. 3, pp. 267–271, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. B. E. A. Lams, A. R. Sousa, P. J. Rees, and T. H. Lee, “Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 15, no. 3, pp. 512–516, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. G. C. Donaldson, T. A. R. Seemungal, I. S. Patel et al., “Airway and systemic inflammation and decline in lung function in patients with COPD,” Chest, vol. 128, no. 4, pp. 1995–2004, 2005. View at Publisher · View at Google Scholar
  23. K. Lai, B. Liu, D. Xu et al., “Will nonasthmatic eosinophilic bronchitis develop into chronic airway obstruction? A prospective, observational study,” Chest, vol. 148, no. 4, pp. 887–894, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. O. Eltboli, V. Mistry, B. Barker, and C. E. Brightling, “Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease,” Respirology, vol. 20, no. 4, pp. 667–670, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. F. A. A. Mohamed Hoesein, P. A. De Jong, J.-W. J. Lammers et al., “Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation,” European Respiratory Journal, vol. 45, no. 3, pp. 644–651, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. C. E. Brightling and L. George, “Is the eosinophil a leading villain in lung function decline?” Chest, vol. 148, no. 4, pp. 844–846, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. J. B. Snoeck-Stroband, T. S. Lapperre, M. M. E. Gosman et al., “Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies,” European Respiratory Journal, vol. 31, no. 1, pp. 70–77, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Singh, U. Kolsum, C. E. Brightling, N. Locantore, and A. Agusti, “Eosinophilic inflammation in COPD: prevalence and clinical characteristics,” European Respiratory Journal, vol. 44, no. 6, pp. 1697–1700, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Weir, H. Zhao, M. K. Han et al., “Eosinophils in chronic obstructive pulmonary disease, the SPIROMICS cohort,” American Journal of Respiratory and Critical Care Medicine, vol. 189, article A5902, 2014. View at Google Scholar